World Media Directory · RSS · Email Newsletters

There were 388 press releases posted in the last 24 hours and 153,356 in the last 365 days.

Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

82,403 Press Releases · RSS · Email

Published on October 17, 2018 - 12:27 GMT

Nutritional High and Aura Health Announce Partnership to Develop International Markets

TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. ("Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) and Aura Health Inc. (“Aura”) (CSE: BUZZ) are pleased to announce the development of a framework to bring …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on October 17, 2018 - 12:01 GMT

New Jersey Dentist Opens New Office Location in Green Brook

Dr. John D. Beckwith has expanded his private practice, Cornerstone Dental, with a second office location in Green Brook, New Jersey. HILLSBOROUGH, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cornerstone Dental is an all-inclusive dental practice offering a …

Distribution channels:
Published on October 17, 2018 - 12:01 GMT

Achaogen Submits Marketing Authorization Application to the European Medicines Agency for Plazomicin

-- MAA submission for complicated urinary tract infections (cUTI), bloodstream infections, and infections due to Enterobacteriaceae in adult patients with limited treatment options -- SOUTH SAN FRANCISCO, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Achaogen …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

Inovio’s DNA-Encoded Monoclonal Antibody (dMAb™) Platform Moves Ahead with Positive Data, Patents and Grants

Two new U.S. Patents for Inovio’s dMAb technology were issued Inovio awarded new $2.2 million Gates Foundation grant to support dMAb development and next-generation dMAb delivery clinical device PLYMOUTH MEETING, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

ORYZON receives approval to start CLEPSIDRA: a Phase IIa clinical trial in Small Cell Lung Cancer with Iadademstat (ORY-1001)

The study will be done in SCLC patients in combination with Platinum-Etoposide chemotherapyMADRID, Spain and CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), (“Oryzon”), a public clinical-stage …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 ...

Showcase represents the public debut of BrainsWay’s Deep TMS system for OCD Healthcare providers will be able to view demonstrations of and purchase the BrainsWay system and OCD helmet at conference booth #109 HACKENSACK, N.J., Oct. 17, 2018 (GLOBE …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

Assertio Therapeutics to Participate in Upcoming Investor Conferences

LAKE FOREST, Ill., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior management will participate at the …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on October 17, 2018 - 12:00 GMT

Intra-Cellular Therapies Presents Results from ITI-214 Phase 1/2 Clinical Trial in Patients with Parkinson’s Disease at 2018 ...

NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced it will present top line results …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

CareDx to Announce Third Quarter 2018 Financial Results on November 8, 2018

BRISBANE, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

Cue Biopharma Announces Strategic Research Collaboration with Albert Einstein College of Medicine to Further the Potential of ...

Collaboration Expands Platform’s Reach Beyond Cancer and Autoimmune Disease to Address T cell Exhaustion in Chronic Infectious Diseases CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc., (NASDAQ: CUE) an innovative immunotherapy …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting

SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced a presentation at the American …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

Clinical Laserthermia Systems (CLS) Signs Exclusive Distribution Agreement with MRI Interventions for USA and Canada

2-Year Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond their Previously Announced Spine and Neuro License Agreement FRAMINGHAM, Mass., Oct. 17, 2018 (GLOBE …

Distribution channels:
Published on October 17, 2018 - 12:00 GMT

IntelGenx Receives Over $1.6 Million from Exercise of Warrants

SAINT LAURENT, Quebec, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that, since September 15, 2018, it has received proceeds of US$1,634,294 as a result of …

Distribution channels:
Published on October 17, 2018 - 11:35 GMT

Intensity Therapeutics to Present Preliminary Data from Clinical Study of INT230-6 at Upcoming Medical Conferences

Posters at European Society for Medical Oncology (ESMO) 2018 Congress and Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting to highlight safety of intratumoral INT230-6 in patients with advanced solid tumorsWESTPORT, Conn., Oct. 17, 2018 ( …

Distribution channels:
Published on October 17, 2018 - 11:30 GMT

MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser ...

IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) and Clinical Laserthermia Systems AB (NASDAQ FIRST NORTH:CLS B), today entered into a collaborative license and co-development agreement to provide …

Distribution channels:
Published on October 17, 2018 - 11:30 GMT

MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser ...

Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) …

Distribution channels:
Published on October 16, 2018 - 23:21 GMT

Imbue Botanicals, LLC has signed a Co-Marketing agreement with Endocanna Health, Inc.

Imbue Botanicals to Co-Market CBD Products with DNA Tester Endocanna Health PALM SPRINGS, CA, UNITED STATES, October 16, 2018 /⁨EINPresswire.com⁩/ -- FOR IMMEDIATE RELEASE…Palm Springs, CA, October 11, 2018 - (Press Release Point) – Imbue Botanicals LLC, …

Distribution channels:
Published on October 16, 2018 - 23:19 GMT

Citizens Commission on Human Rights Shifts the Paradigm in Mental Health Rights

Citizens not only have a right to treatment of their choice. The right to refuse involuntary treatment is as important. WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, October 16, 2018 /⁨EINPresswire.com⁩/ -- Citizens were presented with a completely …

Distribution channels:
Published on October 17, 2018 - 11:08 GMT

ADMA Biologics Receives PDUFA Date for RI-002

Resubmission of Biologics License Application (“BLA”) Reinforces the Company’s Commitment to Commercialize Novel Therapies for Immune Compromised Patients to Address Unmet Medical Needs RAMSEY, N.J. and BOCA RATON, Fla., Oct. 17, 2018 (GLOBE NEWSWIRE) -- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on October 17, 2018 - 11:05 GMT

Sonoma Pharmaceuticals Launches New Ceramax™ Skin Barrier Lotion with Skin-Enriching Lipogrid Technology™

PETALUMA, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue …

Distribution channels:

Previous 4 5 6 7 8 9 10 11 12 13 14 Next

EIN Presswire

Back to top

Quick Links:

Resources:

Press Releases:

Featured Clients:

Help & Information Center:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 202-540-8337 or +1 800-883-2055.
EIN Presswire
Events & Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook